Cancer Therapy

Research shows evidence of synergy and molecular activity of MG98

Published in Cancer Weekly, May 4th, 2004

Two poster presentations - one demonstrating synergistic usage of MG98 in combination with interferon in renal cancer cells and another disclosing anticancer activity of MG98 as a single agent in gastric cancer cells - were presented at the 2004 American Association of Cancer Research's 95th annual meeting in Orlando, Florida.

Abstract #1602, which describes MG98 activity against gastric cancer, was presented by MethylGene, Inc., a private biopharmaceutical company focused on developing new drugs for cancer and infectious diseases. Abstract #1609, which describes the activity of MG98 in combination with interferon against renal cancer cells was presented by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-05-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry